HomeAI · summaries
Storia in 2 fonti
Psychedelics, peptides and GLP-1s
Is biotech taking a trip to the world of psychedelic drugs? Why is Novo Nordisk going after Eli Lilly’s Zepbound ads? | This week on “The Top Line,” Fierce’s Zoey Becker, Will Maddox and Kevin Dunleavy break down a major psychedelics acquisition, a politically charged peptide adcomm and the latest legal clash between the obesity drug giants.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
glossy.co
Wellness Briefing: The peptide pipeline gets new legal momentum, plus news
Glossy checked in with leaders in the peptide space to unpack the results of last week’s FDA advisory committee meetings.
- ·
fiercepharma.com
Lilly, Resilience commit $750M to boost US diabetes, obesity med production
Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies embark on a $750 million investment to increase production of Lilly’s KwikPen injectable device…
